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Background: Visual information comprises one of the most salient sources of information used to control walking
and the dependence on vision to maintain dynamic stability increases following a stroke. We hypothesize,
therefore, that rehabilitation efforts incorporating visual cues may be effective in triggering recovery and
adaptability of gait following stroke. This feasibility trial aims to estimate probable recruitment rate, effect size,
treatment adherence and response to gait training with visual cues in contrast to conventional overground walking
practice following stroke.
Methods/design: A 3-arm, parallel group, multi-centre, single blind, randomised control feasibility trial will compare
overground visual cue training (O-VCT), treadmill visual cue training (T-VCT), and usual care (UC). Participants
(n = 60) will be randomly assigned to one of three treatments by a central randomisation centre using computer
generated tables to allocate treatment groups. The research assessor will remain blind to allocation. Treatment,
delivered by physiotherapists, will be twice weekly for 8 weeks at participating outpatient hospital sites for the O-
VCT or UC and in a University setting for T-VCT participants.
Individuals with gait impairment due to stroke, with restricted community ambulation (gait speed <0.8m/s), residual
lower limb paresis and who are able to take part in repetitive walking practice involving visual cues (i.e., no severe
visual impairments, able to walk with minimal assistance and no comorbid medical contraindications for walking
practice) will be included.
The primary outcomes concerning participant enrolment, recruitment, retention, and health and social care
resource use data will be recorded over a recruitment period of 18 months. Secondary outcome measures will be
undertaken before randomisation (baseline), after the eight-week intervention (outcome), and at three months
(follow-up). Outcome measures will include gait speed and step length symmetry; time and steps taken to
complete a 180° turn; assessment of gait adaptability (success rate in target stepping); timed up and go; Fugl-Meyer
lower limb motor assessment; Berg balance scale; falls efficacy scale; SF-12; and functional ambulation category.
Discussion: Participation and compliance measured by treatment logs, accrual rate, attrition, and response variation
will determine sample sizes for an early phase randomised controlled trial and indicate whether a definitive late
phase efficacy trial is justified.
Trial registration: Clinicaltrials.gov, NCT01600391.
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Recovery of walking function is a major goal of rehabilita-
tion after stroke. Although many patients regain a basic
locomotor pattern, one study has reported that only 7% of
patients discharged from rehabilitation are able to walk
safely in the community [1]. A further study suggests that
as many as 50% of stroke patients discharged into the com-
munity will fall and that a large proportion of these falls will
occur during manoeuvres in which the basic walking pat-
tern needs to be adapted, such as in turning [2]. Recent
studies have postulated that impairments in gait which per-
sist after stroke, such as diminished speed, asymmetries in
step lengths and gait phase durations, may have an under-
lying impoverished ability to adapt the gait pattern as re-
quired to mobilize independently [3]. Hence, the incidence
of falls after stroke may be due to impaired ability to flexibly
adapt an already impoverished coordination pattern during
straight walking [4] in order to turn, step over an obstacle,
target a safe foot-placement, or alter speed as needed for in-
dependent community ambulation [3].
Current approaches to rehabilitation of gait following
stroke are varied, based on different models of motor
physiology and disease recovery, but most share
targeting motor impairments during straight walking
only as opposed to adaptive walking ability [5]. Overall,
evidence indicates that current rehabilitation approaches
have only modest effects on impairment and activity
[6,7]. Therefore, new more effective treatments need to
be developed and tested within robust, early phase stud-
ies. Treatments should be supported by a sound theoret-
ical basis; specifically, by an understanding of the
mechanisms which cause gait deficits and proposed
treatment effects [7].
Evidence from the motor learning literature indicates that
effective neurorehabilitation requires task-specific practice
that should be varied, intensive [7], and driven by a com-
bination of extrinsic movement goals and implicit know-
ledge of movement control [8]. A recent synthesis of
existing evidence further suggests that task-specific practice
of walking which targets restoration of gait coordination
patterns (temporal and spatial symmetry) may be beneficial
in improving overall walking function [4]. The goal of nor-
malizing walking patterns, particularly symmetry, is contro-
versial given enduring neuromuscular asymmetries after
stroke [9]. However, meta-analysis indicates that interven-
tions that show most promise for improvements in walking
function (task-specific locomotor practice and auditory cue-
ing) both involve repetition of a more normative gait pat-
tern, while the least beneficial (ankle-foot orthoses/
functional electrical stimulation and exercise) do not expli-
citly practice a normative gait pattern [4]. The findings
from the systematic examination of the evidence base lend
support to the notion that repeated exposure to normalized
movement patterns could bring about positive changes inmotor control [10,11] and support the development of in-
terventions that enable patients to undertake intensive
practice of functional tasks in a manner that drives an
optimised movement pattern.
Rehabilitation approaches identified as showing the
most promise for eliciting normalized gait coordination
patterns utilised auditory cues as extrinsic movement
goals [4]. While there are good indications that stroke
survivors are able to adjust gait coordination in response
to auditory cues [12], some studies have shown that vis-
ual cues may be more effective in triggering gait adjust-
ments in healthy participants walking straight [13].
Current understanding of motor control of locomotion
indicates that visual information comprises one of the
most important and salient sources of information used
during walking [4,14] and that stroke survivors have
been reported to become more dependent on vision to
maintain dynamic stability [15]. Paradigms involving
walking in response to visual cues have recently begun
to be used to investigate functional walking tasks, in-
cluding turning and obstacle avoidance, in various pa-
tient populations, both overground and on a treadmill
[13,16-18]. Despite numerous small experimental studies
reporting the potential efficacy of using visual cues to
enhance gait function, to date, there have been no robust
clinical trials of these interventions that we are aware of.
Based on the current understanding of motor control
of walking and stroke rehabilitation, we hypothesize that
visual cues would be more effective in triggering gait re-
covery and adaptability following stroke than interven-
tions not including visual cues. It is hypothesized that
anticipated improvements to functional gait may be de-
rived from task-specific practice of regulating changes in
the relation between the base of support and the centre
of mass occurring when step widths and lengths change,
which is crucial for dynamic balance control.
The study reported here comprises an early phase pilot
randomised controlled trial (RCT) aiming to examine
the feasibility of a trial comparing task-specific loco-
motor practice incorporating visual cues to usual care
rehabilitation, which does not include visual cues. Spe-
cifically, the study aims to:
1. Characterise participants who are included and
excluded into the trial from four NHS trusts in the
West Midlands.
2. Provide an estimation of recruitment rates to the
trial across the multiple sites.
3. Estimate the adherence of participants allocated to
the visual cue training (VCT) to the prescribed dose.
4. Present the completeness of proposed outcome data.
5. Calculate sample sizes for a subsequent definitive
trial, based on measured changes in performance for
usual care and VCT intervention groups.
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intervention.
7. Determine therapist acceptability for delivering the
VCT interventions.
8. Collate health and social care resource data to
inform data collection methods for an economic
evaluation in the subsequent definitive trial.
Methods
Design
This is a pilot, multi-centre, randomised [1:1:1], stratified
by gait speed (Severe group: <0.4 m/s; Moderate group:
between 0.4 m/s and 0.8 m/s [19]), controlled trial with
three parallel groups and single-blind assessment
conducted in the UK (four sites).
Randomisation
The randomisation will be created using StataSEv9
(StataCorp, College Station, TX, USA) statistical soft-
ware with a 1:1:1 allocation using random permuted
blocks of varying size (for unpredictable allocation se-
quence [20]), prepared by the Nottingham Clinical Trials
Unit (NCTU) statistician and held on a secure server.
To obtain balanced groups on severity, block randomisa-
tion will be used to stratify participants into two groups
according to overground gait speed (Severe group: <0.4
m/s; Moderate group: between 0.4 m/s and 0.8 m/s
[19]). Participants will be randomly assigned to one of
three treatment groups by means of a web-basedScreening an
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Figure 1 Trial design flow diagram.randomisation system accessed by a researcher after
obtaining consent and performing baseline assessments.
Participants and therapists will not be blinded to the
intervention allocation. The treating therapist will be no-
tified of treatment allocation directly from the NCTU by
email. To preserve allocation concealment [20], the in-
dependent assessor responsible for collecting the out-
come measures will receive only blinded confirmation of
randomisation. The assessor will record a guess of par-
ticipants’ group allocation for later examination of the
success of blinding.
The sequence from screening, enrolment (provision of
written informed consent) and randomisation is repre-
sented in a flow diagram Figure 1.
Participants
Combined inclusion and exclusion criteria are as
follows:
 Community dwelling post-stroke participants over
18 years of age identified at discharge from inpatient
acute wards and at referral to community and
outpatient services.
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Scale [22] score of greater than 3;
○Without gait deficits attributable to non-stroke
pathology.
 Able to take part in practice of walking including
visual cues as indicated by:
○Walking with minimal assistance, functional
ambulation category [23] of 3 or more;
○ Ability to follow a three-step command (as
assessed by modified mini-mental status exam);
○Without visual impairments preventing use of
visual cue training.
 Medically stable to take part in walking
rehabilitation as indicated by:
○Without concurrent progressive neurologic
disorder, acute coronary syndrome, severe heart
failure, confirmed or suspected lower-limb
fracture preventing mobilization;
○ Not requiring palliative care.
Patient characteristics including stroke date and lesion
location, demographics, Sheffield screening test [24],
mini mental state examination [25], pre-morbid modi-
fied Rankin Scale [22], and visual attention (Apple Test)
[26] will be recorded.
Interventions
This study will contrast the feasibility and potential effi-
cacy of two forms of VCT to usual care walking (UC) re-
habilitation; overground VCT walking (O-VCT) and
treadmill-based VCT (T-VCT). In T-VCT, a force-
instrumented treadmill (CMill, Forcelink, NL, USA) will
be used to illuminate footfall targets at specified loca-
tions 2–3 steps in advance, in line with current know-
ledge of gaze behaviour during locomotion [27]
according to gait event detection of the ongoing gait
cycle [28]. In O-VCT, therapists will manually place
footfall target at specified locations, according to the
baseline gait assessment, along an overground walkway.
Both VCT interventions are designed to target the es-
sential control and functional requirements of walking,
namely (1) speed, (2) symmetry (equality of step length),
and (3) adaptability to behavioural goals of the partici-
pant and environmental constraints, including abilities
for turning and shortening, lengthening or narrowing
(e.g., tandem walking) of steps [29]. The potential effi-
cacy, feasibility and acceptability of both O-VCT and T-
VCT treatment modalities are being investigated be-
cause some studies [7,30] have indicated support for
mechanically aided rehabilitation approaches due to the
capacity to deliver high dosage and high intensity train-
ing protocols incorporating motor learning and motor
control theoretical perspectives. However, the efficacy of
electromechanically aided walking practice has not beenestablished and so they are not often offered as part of
current practice [31-34].
There will be three treatment arms all of which share
the same frequency, duration and intensity in terms of
encouraging therapists to maintain equal session dura-
tions and same intensity of continuous walking. Partici-
pants will receive walking practice for one hour, 2 times
per week, for 8 weeks duration. The target exercise cap-
acity is 20 minutes of continuous, independent walking,
with symmetrical step length. A resource usage log will
record all other aspects of therapy such as occupational
therapy, for which participants are referred and will con-
tinue to receive, irrespective of treatment allocation.
O-VCT and UC will be delivered in four participating
hospital settings embedded within current service
provision. Only one specialized treadmill (CMill,
Forcelink, NL, USA) for T-VCT is available to the study
and so the feasibility of this treatment is being assessed
through treatment delivery at one regional treatment site
(within a mean 11 mile radius of participating NHS sites
delivering O-VCT and UC treatment arms) at the Uni-
versity of Birmingham. Patients recruited from the par-
ticipating hospitals will travel to the University to
receive this arm of training if they are randomised to it.
This is not additional travel, but in lieu of their normal
transfer to hospital for treatment. This model of a re-
gional treatment centre is in line with the provision of
other specialist rehabilitation services such as functional
electrical stimulation falls efficacy scale and gait assess-
ment in this part of the UK.
Treating therapists will receive training and a detailed
treatment manual to promote consistency between ther-
apists and sites. Adherence to the intervention by thera-
pists will be assessed during their involvement in the
trial by A. Wimperis and K. Hollands through video ob-
servation at weeks 2 and 6 of each therapists’ first treat-
ment period. Further training for the therapist will be
provided, if necessary, to improve compliance with treat-
ment protocols. The involvement of different therapists
and different sites promotes generalizability, providing
multiple viewpoints regarding the treatment and its
feasibility for delivery across different modes of service
provision.
VCT interventions (Figure 2 and Table 1)
Training of speed and symmetry
To improve symmetry we increase the shorter step
length incrementally by 10% of the maximum step
length. Patients are presented with stepping targets
(white rectangles, 8 cm deep × 40 cm wide (which
adhere to the walkway in O-VCT or are illuminated
on the treadmill belt in T-VCT) along a 5 m long
walkway (O-VCT), or 3 m treadmill belt (T-VCT), to
which they must aim to step on. In both VCT
Figure 2 Illustration of training target placement for O-VCT and T-VCT. (a) O-VCT symmetry, (b) O-VCT adaptability, (c) O-VCT turning,
(d) T-VCT symmetry, (e) T-VCT adaptability, (f) T-VCT turning.
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two steps in advance in accordance with visuo-motor
control literature indicating where healthy adults typ-
ically look while walking to targets [35]. The width of
the stepping targets corresponds to half of the width
of the walkway, allowing for self-selected width of
stepping such that medial stabilisation strategies are
not constrained while patients are being challenged to
alter step length and speed. The depth of the targets
corresponds to the variability in step length reported
in stroke patients [36]. Participants are instructed to
step on the targets with any part of the foot. Thus,
the depth of the targets has been selected such that
they should only be missed if the error in footfall lo-
cation is greater than usual variability. The location
of the stepping targets is predetermined according to
goals for 10% increments in improved symmetry and
altered as treatment progresses to increase intensity.
The location of targets is calculated and prescribed to
treating clinicians by the research assessor following
baseline overground gait assessment and prior to the
start of training. Prescribed targets for progressing
speed (beyond 0.4 m/s or 0.8 m/sfor the moderate
and severely impaired, respectively) will also be pro-
vided according to 10% increments to baseline mea-
sures. Participants are allowed to use a walking aid
and prescribed ankle/foot orthoses or to grasp the
therapist’s hand, wall or handrail for safety. Stepping
towards increasingly symmetrical targets is practiced
at increasing walking speed as treatment progresses
(Table 1).Adaptability practice
Stepping targets are placed to elicit step adjustments
similar to that required in environments with clutter or
situations requiring alterations to foot-placement or dir-
ection. Targets are located along the walkway/treadmill
belt to elicit lengthening, shortening (±25% of baseline
step lengths) and narrowing of paretic and non-paretic
steps. In the T-VCT treatment arm, illuminated targets
shift to elicit step alterations at varying times in the on-
going gait cycle and obstacles are presented in red and
white stripes to be avoided (Figure 2e). Thus with the
exception of obstacle avoidance in T-VCT and the ability
to practice changes to walking in time-critical manner,
the number and magnitude of each type of step alter-
ation are the same across both VCT treatment arms.
Turning practice
Turning is performed by walking between targets lo-
cated 1 m apart alternately on the left and to the right of
the walkway/treadmill belt. Participants are instructed to
‘turn to walk between the obstacles’ in such a fashion as
to slalom their way across the walkway/treadmill belt. In
O-VCT, once the end of the path is reached, participants
practice a 180° turn using a horizontal marker to cue
foot placement according to a two-step turn seen in
healthy adults, [35,37,38]. Participants then slalom their
way back down the path.
Each session will consist of 5 min each of warm up
and stretching, 20–30 min (plus 10 min for rests as
required) overground walking practice training
programme and a 5 min cool-down. Each of the
Table 1 Visual cue training (VCT): treatment progression
Progression Treatment goal categories
treatment phase (sessions) Walking speed target Symmetry target Turning ability target Gait adaptability/ translation
to functional mobility
Intensity
I (1–4) Increasing walking speed
in 10% increments, as
tolerated, from baseline to
the target threshold
(either 0.4m/s or 0.8m/s
depending on initial SSWS)
Improving symmetry of
(a)step-length, (b) stance
and swing phases in 10%
increments, as tolerated
Four 5 min bouts of walking
to total 20 min of stepping
with each bout addressing
one of the goals at a time
II (5–10) Increasing walking speed
in 10% increments, as
tolerated, from baseline
to the target threshold
(either 0.4m/s or 0.8m/s
depending on initial SSWS)
Improving symmetry of
step-length, stance and
swing phases in 10%
increments, as tolerated,
while maintaining new
walking speed
10% improvement in turning
towards ability to turn in two
steps, 2 seconds in either
direction while maintaining
new walking speed
10% improvement in the number
of failures to hit targets presented
unpredictably in timing and location
on both limbs while maintaining
new walking speed
Increase bout duration and
decrease number of bouts;
however, each goal is still
addressed individually in
blocks of practice
III (11–16) Practice at maintenance
of walking speed over
threshold and at altering
speed as dictated by
varying speed of
presentation of footfall
targets
Practice at maintenance
of symmetrical stepping
Two steps, 2 seconds in
either direction when turns
are unpredictable
Able to alter stepping pattern to
hit targets presented unpredictably
in timing and location on either
limb
20–30 min of sustained
*good quality stepping
*Good quality stepping is defined as walking with spatial symmetry of stepping pattern and dynamic trunk control during adaptations to step length and turning.
Self selected walking speed SSWS.
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and turning) is practiced in blocks at increasing speed as
treatment intensity progresses. Thus, walking is prac-
ticed in accordance with current recommendations of
motor learning [8,39], i.e., with many repetitions with in-
creasing intensity, variation of parameters, in response
to external demands and using implicitly known (visuo-
motor) control of the gait cycle [35].
Treatment will progress in phases layering practice of
walking speed, symmetry, adaptability and turning in
bouts of practice, as detailed in Table 1. Participants will
continue to the next treatment phase even in cases
where goals have not been met.
Walking speed in the O-VCT arm will be monitored
and progressed by timing walks, with therapists’ use of a
stopwatch, and feedback to the participant. T-VCT treat-
ment will be delivered by an experienced, HPC regis-
tered research therapist. The CMill uses an assessment
of each footfall to determine the timing and location of
visual cues projected as light targets shone 2–3 steps
ahead on the treadmill. The location of visual cues and
progression of treatment will therefore be pre-
programmed according to baseline gait parameters in
the same manner as for the O-VCT treatment. A safety
harness is worn at all times during T-VCT treatment.Usual care
The purposes of the UC group are to provide (1) a task-
specific-based intervention that does not include use of
visual cues specifically designed to influence quality or
adaptability of gait; (2) an equal number of interactions
and time spent with a physical therapist to minimize any
potential for bias due to differential exposure and
minimize the risk for differential loss to follow-up; and
(3) a credible training program so that the participants
would consider themselves involved in meaningful ther-
apy activity. UC is standard NHS physiotherapy, broadly
defined as a task-specific-based intervention that may in-
volve walking overground or on a treadmill; components
of gait (such as weight shifting or initiation); exercises
aimed at improving upper or lower extremity strength;
balance and coordination; prescription of assistive de-
vices (such as orthotics or walking aides). UC may in-
volve any standard equipment or objects such as cones
or beanbags, which may be incorporated into walking
practice for functional use, e.g., picking up. These ob-
jects will not be used specifically as visual cues for foot
placement, symmetry or timing of gait, or by way of
aiming to avoid or hit targets. The content of UC treat-
ment will be captured by a treatment log for the purpose
of capturing UC physiotherapy specifically used to influ-
ence walking. Therapists complete the log by ticking
relevant categories for environment, aids and equipmentused, activities undertaken, facilitation and feedback pro-
vided, and duration of each treatment session.
Primary outcomes
Primary outcome measures for this early phase trial
focus upon the feasibility and safety of treatment. In
order to determine whether a large late phase trial is
warranted, we are investigating recruitment, participa-
tion, compliance, and safety of the interventions. Out-
come measures therefore include:
1. The numbers of patients willing to be recruited into
both control and VCT groups.
2. The willingness of physiotherapists at each
collaborating site to enrol patients, i.e., the number
of potentially eligible participants referred to the
study.
3. The numbers of patients who do not complete the
allocated treatment, thus dropping out of the study,
and the reasons for dropping out.
4. Completeness of outcome data, i.e., percentage of
patients with no missing values in outcome
assessments.
5. Number and type of adverse events that can be
directly attributed to the project intervention.
Secondary outcome measures
Potential for efficacy will be assessed through measures
reflecting the primary aims of the intervention, i.e.,
speed and symmetry, turning ability, and adaptability of
walking.
Primary measures of walking ability:
1. Gait speed: Proportion of participants achieving a
gait speed of 0.4 m/s and 0.8 m/s, measured during
a 10 m walk [40]. Perry et al. [19] have shown that
these gait speed classifications correspond to
walking abilities in the community, with a gait speed
of <0.4 m/s for household walkers, 0.4–0.8 m/s for
limited community walkers, and >0.8 m/s for
community walkers. It has been demonstrated that
progressing from one of these classifications to the
next correlates with improvement in physical
functioning and quality of life [41] and these
categories also correspond with changes in the
functional ambulation category, a categorical scale
rating level of skill in functional ambulation [23].
2. Symmetry and turning ability: Time taken (s) and
number of steps to complete a 180° turn will be
measured on the GaitRite instrumented walkway.
Time taken to turn will be calculated as the
difference (in time) between the first footfall over a
line (tape mark) on the pressure sensitive walkway
delineating where to turn and the first footfall over
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increased number of steps to turn have all been
identified as performance measures which may be
indicative of difficulty turning and increased falls
risk [37,42]. Additionally, spatial-temporal gait
parameters will be measured during walking over
the GaitRite to quantify symmetry of left and right
steps. Stepping strategies during turning will be
measured through gait parameters calculated by
GaitRite software including step width, step length
(relative to line of progression) [43], and single
support time during turning steps.
3. Adaptability of gait: The number of times participants
fail to hit stepping targets arranged to cue varying
(baseline step length ±30% and medial) foot placements
on the overground walkway (as previously described
and illustrated in Figure 2). A target is classified as
missed if the participant is visually observed to be
unable to place the whole foot accurately on the target
independently and safely (according to visual
inspection). The assessor documents the number of
targets missed in three consecutive passes of the
walkway (a total of 48 targets including three attempts
of each step adjustment on each side) as well as time
taken to complete each pass of the walkway and a
score for the level of supervision or assistance required.
We will further explore the relationship between gait
impairments and activity level measures of independence
of functional walking in the community. Therefore, the
following secondary outcome measures are included:Table 2 Assessment schedule and measures
Outcome measure Clinical
status
baseline Post
Stroke date and lesion location X
Demographics X
Sheffield screening test [34] X
Mini mental state examination [35] X
Premorbid modified Rankin Scale [19] X
Visual attention – Apple test [36] X
Gait assessment (symmetry measures) X
Gait speed (10 m walk test) X
Gait adaptability (number of targets missed) X
Timed up and go [37] X
Fugl-Meyer [18] motor assessment (lower
limb extremity)
X
Berg balance scale [38-40] X
Functional ambulation classification [41] X
Short form 12 (SF-12) [42,43] X
Falls efficacy scale [44] X The timed up and go test has previously been
shown to have good test-retest reliability in stroke
patients [44,45]. The time taken with a stopwatch
will be used to test ability to walk and turn in the
context of this standardised test of everyday
functional mobility.
 Fugl-Meyer assessment [21] will be used to assess
changes in motor and sensory impairment.
 Berg balance scale [46,47] will be used to capture
any effects of interventions on balance.
 Overall independence of mobility in the community
setting will be rated using the functional ambulation
category [48].
 Falls efficacy scale [49] will be used to assess
changes in confidence to walk without falling, which
may be expected as a result of practice of adaptable
walking.
 SF-12 [50,51]. This is a short-form health survey
with only 12 questions. It yields an 8-scale profile of
functional health and well-being scores, including
physical functioning, and social, emotional, mental
and general health, and has been included to
measure effects on broader quality of life (Table 2).Economic evaluation
The purpose of the economic evaluation in the pilot trial
is to identify all the relevant health and social care costs,
and pilot methods for collecting cost data (data collec-
tion forms, questionnaires). This will provide initial cost
information and enable effective resource use and cost-intervention (8 weeks post-
randomisation)
Follow-up (3 months post-
randomisation)
X X
X X
X X
X X
X X
X X
X X
X X
X X
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quent definitive trial.
Data collection
Details of all travel to and equipment used for patient
therapy will be recorded and costs established. Therapist
time spent with the patient and location of therapy will
be recorded in order to calculate the cost of an individ-
ual session. Any additional stroke rehabilitation-specific
primary and secondary care and social services resource
use information will be collected in a self-report log
from each patient. Quality of life will also be measured
using responses to the SF-12 at baseline, 8 weeks and 3
months.
Analysis
Unit costs will be applied to all items of resource use,
and health and social care costs per patient will be esti-
mated. Responses to the SF-12 will be converted to SF-
6D scores, allowing the calculation of quality adjusted
life years (QALYs) per patient over the 3-month period.
A cost-consequence analysis will be undertaken present-
ing all costs and outcomes in a disaggregated form for
each trial arm. Within the economic evaluation, along-
side a larger trial, a cost-effectiveness analysis and cost-
utility analysis are proposed to determine the cost per
unit reduction in impairment, and cost per QALY gained
(using the SF-6D derived from SF-12 responses).
Assessment of safety and adverse event monitoring
The risk of serious or adverse events from taking part in
the study is considered low; however, as with conven-
tional gait rehabilitation, there is a small possibility of in-
jury as a result of a fall. No special safety assessments
are planned. Clinicians will be advised that participant
safety is paramount. Walking will be practiced within
limits considered by the therapist to be safe at the time
and targets for treatment progression will only be used
as a guideline. In addition to the compliance of standard
NHS reporting procedures, adverse events, including
falls, will be reported immediately to the study coordin-
ating centre via email using an adverse event form and
then quarterly to the Trial Steering Committee (TSC)
and Data Monitoring and Ethics Committee (DMEC).
Adverse events will be reviewed immediately by the
treating therapist and the research therapist to deter-
mine the severity, cause and likelihood of recurrence.
Training will be discontinued if the treating therapist or
research therapist deems continuation unsafe.
Ethical approvals and data monitoring
Ethical approval has been granted by the NRES Commit-
tee West Midlands (11/WM/0167). R&D Governance
approval is provided by the University of Salford; BBCCLRN RM&G Consortium Trusts (284.74472.P); Heart
of England NHS Foundation Trust (2011007SKE); South
Warwickshire NHS Foundation Trust (74472); and
Sandwell and West Birmingham Hospitals Trust
(11STR07). The trial is registered on the ClinicalTrials.
gov database (NCT01600391) and adopted by the Stroke
Research Network UKCRN (ID11147). A combined TSC
and independent DMEC will be used to monitor the trial
conduct. The grant holding team meet to review project
management on a quarterly basis with day-to-day man-
agement overseen by the chief investigator CI.
Data quality is ensured both through the monitoring
of the TSC and DMEC, and through the engagement of
data services of the NCTU. The NCTU maintains the
computer-based database of case report forms and has
developed and tested the validations for entering study
data into the database.
Compliance to the trial protocol by participating NHS
sites is ensured by provision of a treatment manual and
training of all participating NHS therapists by the re-
search therapist and assessor, as well as video observa-
tion of treatment delivery.
Statistical analysis
This feasibility study is designed primarily to test re-
cruitment, retention and the completeness of data that
could be expected within a definitive multicentre trial,
hence, there will be no formal statistical assessment of
clinical efficacy. Secondary outcome measures will be
summarised and mean differences between the arms will
be calculated and presented with confidence intervals to
determine sample sizes for a subsequent late phase trial.
No interim analysis will be conducted.
Screening logs will be held centrally for each site and
from which monthly recruitment rates will be accrued
together with the percentage of participation refusals.
The screening data will be analysed to determine charac-
teristics of the excluded samples. The number of with-
drawals before and after randomisation will be
monitored by the NCTU together with a primary reason
for withdrawal whenever possible. Demographic and
other baseline data will be summarised by descriptive
statistics (number, mean, standard deviation, median,
minimum and maximum) or frequency tables, stratified
by treatment.
Compliance in terms of treatment sessions attended
will be summarised by descriptive statistics (number,
mean, standard deviation, median, minimum and max-
imum) or frequency tables, stratified by treatment. The
frequency, type and duration of exercises will be
summarised from treatment logs recorded by physio-
therapists at each session. These will be collated after
the follow-up assessment to prevent unblinding. The
completeness of treatment log data will then be
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A telephone interview will be conducted at the end of
the patients’ participation to determine patient views on
the VCT training. Focus group meetings will be
conducted with therapists after the study to ascertain
professional opinions regarding delivery of the interven-
tions. Patient and therapist feedback will be synthesised
to determine necessary changes to the interventions.
Discussion
Recovery of independent mobility after stroke is a major
priority of rehabilitation but evidence indicates that
current approaches have only modest effects on walking
impairment and activity [6,7]. In accordance with the
suggested need for studies in this area [7], this early
phase trial will test the feasibility, safety and potential ef-
ficacy of two novel approaches which offer repetitive
task-specific practice of walking in response to visually
cued external demands designed to exploit implicitly
known visuo-motor control of the gait cycle. Results will
indicate potential response (e.g., a confidence interval in-
dicating if, and which of the VCT interventions has the
potential to be superior to the UC) to walking practice
incorporating visual cues, stepping adaptability and turn-
ing practice in contrast to UC in community-dwelling
stroke survivors.
For clinicians, this research will help to define an
evidence-based protocol for VCT within routine prac-
tice, which is targeted towards increased speed, im-
proved spatial symmetry and dynamic gait control
during adaptations to step length and turning. It is antic-
ipated that the resulting improvements to functional gait
will reduce dependence upon carers and promote phys-
ical activity and social participation for people with
stroke, and further, that reduced health-care costs will
reflect fewer falls.
Trial status
Recruitment began in June 2012. To date 364 stroke pa-
tients have been screened for eligibility, 32 potentially eli-
gible participants have been approached for consent, and 8
have declined. Out of the remaining 24 eligible participants,
16 have provided consent and 8 consents are pending; 11
participants have been randomised and 5 are awaiting base-
line assessment prior to randomisation.
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